동물실험에서의 뇌 염증과 간질
Brain Inflammation and Epilepsy in Experimental Animals
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In epilepsy, there have been increasing experimental reports on the interaction between seizures and inflammation. Proinflammatory cytokines such as interleukin-1β, tumor necrosis factor-α, and interleukin-6 are rapidly increased after seizure was induced in experimental rodents. Preexisting inflammation enhances vulnerability of hippocampal neurons to status epilepticus, resulting in neuronal injury in the developing brain. Although too little is known about the role of inflammation in brain with seizures, actions of anti-inflammatory drugs, and how neuroprotection would be produced, increasing evidence has been presented that multiple mechanisms may underlie neuronal injury following inflammation-exacerbated status epilepticus. In this article will be reviewed the experimental studies for the role of brain inflammation in epilepsy.
Abstract
In epilepsy, there have been increasing experimental reports on the interaction between seizures and inflammation. Proinflammatory cytokines such as interleukin-1β, tumor necrosis factor-α, and interleukin-6 are rapidly increased after seizure was induced in experimental rodents. Preexisting inflammation enhances vulnerability of hippocampal neurons to status epilepticus, resulting in neuronal injury in the developing brain. Although too little is known about the role of inflammation in brain with seizures, actions of anti-inflammatory drugs, and how neuroprotection would be produced, increasing evidence has been presented that multiple mechanisms may underlie neuronal injury following inflammation-exacerbated status epilepticus. In this article will be reviewed the experimental studies for the role of brain inflammation in epilepsy.
참고문헌 (49)
- Beamer NB., "Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke", Ann Neurol, 37, pp.800~805 (1995)
- Minghetti L., "Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide", Prog Neurobiol, 54, pp.99~125 (1998)
- Nelson PT., "Microglia in diseases of the central nervous system", Ann Med, 34, pp.491~500 (2002)
- Svenungsson E., "Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus", Ann Rheum Dis, 60, pp.372~379 (2001)
- Krizanac-Bengez L., "The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostasis and pathophysiology", Neurol Res, 26, pp.399~411 (2004)
- Pachter JS., "The blood- brain barrier and its role in immune privilege in the central nervous system", J Neuropathol Exp Neurol, 62, pp.539~604 (2003)
- Lossinsky AS., "Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions: review", Histol Histopathol, 19, pp.535~564 (2004)
- Ransohoff RM., "Three or more routes for leukocyte migration into the central nervous system", Nat Rev Immunol, 3, pp.569~581 (2003)
- Fabene PF., "A role for leukocyte-endothelial adhesion mechanisms in epilepsy", Nat Med, 14, pp.1377~1383 (2008)
- Kleen JK., "Brain inflammation initiates seizures", Nat Med, 14, pp.1309~1310 (2008)
- Allan SM., "Cytokines and acute neurodegeneration", Nat Rev Neurosci, 2, pp.734~734 (2001)
- Peltola J., "Cytokines and seizures", Arch Neurol, 58, pp.1168~1170 (2001)
- De Simoni MG., "Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus", Eur J Neurosci, 12, pp.2623~2633 (2000)
- Cai Z., "Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat", Brain Res, 975, pp.37~47 (2003)
- Vezzani A., "Brain inflammation in epilespy: experimental and clinical evidence", Epilepsia, 46, pp.1724~1743 (2005)
- Labow M., "Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I recepter-deficient mice", J Immunol, 159, pp.2452~2461 (1997)
- Vezzani A., "Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis", Epilepsia, 43(5), pp.30~35 (2002)
- Panegyres PK., "The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene", J Neurol Sci, 154, pp.123~132 (1998)
- Dube C., "Interleukin-1beta contributes to the generation of experimental febrile seizures", Ann Neurol, 57, pp.152~155 (2005)
- Wang S., "Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons", J Pharmacol Exp Ther, 292, pp.497~504 (2000)
- Ye ZC., "Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide", Neuroreport, 7, pp.2181~2185 (1996)
- Kamikawa H., "IL-1beta increases norepinephrine level in rat frontal cortex: involvement of prostanoids, NO, and glutamate", Am J Physiol, 275, pp.803~810 (1998)
- Balosso S., "Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors", Ann Neurol, 57, pp.804~812 (2005)
- Yuhas Y., "Bidirectional concentration-dependent effects of tumor necorsis factor alpha in Shigella dysenteriae- related seizures", Infect Immun, 71, pp.2288~2291 (2003)
- Samland H., "Profound increase in sensitivity to glutamatergic but not cholinergic agonist induced seizures in transgenic mice with astrocyte production of IL-6", J Neurosci Res, 73, pp.176~187 (2003)
- Sankar R., "Serum neuron-sepecific enolase is a marker for neuronal damage following status epilepticus in the rat", Epilepsy Res, 28, pp.129~136 (1997)
- Holmes GL., "Seizure-induced neuronal injury: animal data", Neurology, 59, pp.3~6 (2002)
- Cilio MR., "Long-term effects of status epilepticus in the immature brain are specific for age and model", Epilepsia, 44, pp.518~528 (2003)
- Haas KZ., "Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling", Hippocampus, 11, pp.615~625 (2001)
- Sankar R., "Patterns of status epilepticus-induced neuronal injury during development and long-term consequences", J Neurosci, 18, pp.8382~8393 (1998)
- Qiu J., "Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans", J Neurosci, 22, pp.3504~3511 (2002)
- Dinkel K., "Novel glucocorticoid effects on acute inflammation in the CNS", J Neurochem, 84, pp.705~716 (2003)
- Yang L., "Lipopolysaccharide administration enhances hypoxic-ischemic brain damage in newborn rats", J Obstet Gynaecol Res, 30, pp.142~147 (2004)
- Lee SH., "Kanic acid-induced seizures cause neruronal death in infant rats pretreated with lipopolysaccharide", Neuroreport, 11, pp.507~510 (2000)
- Auvin S., "Inflammation exacerbates seizure-induced injury in the immature brain", Epilepsia, 48(5), pp.27~34 (2007)
- VanLandingham KE., "Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions", Ann Neurol, 43, pp.413~426 (1998)
- Wallenstein MC., "Attenuation of penicillin models of epilepsy by nonsteroidal anti-inflammatory drugs", Exp Neurol, 98, pp.152~160 (1987)
- Srivastava AK., "Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice", Indian J Physiol Pharmacol, 45, pp.475~480 (2001)
- Matoth I., "Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells", Neurosci Res, 38, pp.209~212 (2000)
- Paoletti AM., "Systemic administration of N-omega-nitro-l-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat", Exp Neurol, 49, pp.349~355 (1998)
- Nakayama M., "Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia", Proc Natl Acad Sci USA, 95, pp.10954~10959 (1998)
- Baran H., "The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid- induced seizures and neurotoxicity", Brain Res, 646, pp.201~206 (1994)
- Kondo F., "Indomethacin inhibits delayed DNA fragmentation of hippocampal CA1 pyramidal neurons after transient forebrain ischemia in gerbils", Brain Res, 791, pp.352~356 (1998)
- Baik EJ., "Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus", Brain Res, 843, pp.118~129 (1999)
- Zhu S., "Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice", Nature, 417, pp.74~78 (2002)
- Stirling DP., "Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury", J Neurosci, 24, pp.2182~2190 (2004)
- Wang J., "Minocycline up-regulate Bcl-2 and protects against cell death in mitochondria", J Biol Chem, 279, pp.19948~19954 (2004)
- Tikka TM., "Minocycline provides neuroprotection against N-methyl-D- aspartate neurotoxicity by inhibiting microglia", J Immunol, 166, pp.7527~7533 (2001)
- Tsuji M., "Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model", Exp Neurol, 189, pp.58~65 (2004)
